Innovative drugs
Sanofi-GSK next-generation COVID-19 booster delivers strong immune response against varian...
Next-generation booster vaccine candidate delivers immune boost in adults primed with mRNA vaccines; with a stronger...
#NewMember | "AseBio will enable us to provide differential and disruptive value"
Meet Mikrobiomik, our new member. We talk with Juan Basterra, CEO of the company
Peaches Biotech publishes positive “in vivo” results of its drug PRS CK STORM
The results show the high efficacy and safety of PRS CK STORM as a medicine to prevent and treat the cytokine storm...
PharmaBoardoom points out VIVEbiotech as one of the ten Spanish Biotechs to watch in 2022
PharmaBoardroom, a leading British media specialized in the health sector, has published an article in which it...
The Spanish company Peaches Biotech deciphers the language that immune cells use to commun...
Peaches Biotech publishes in Biomolecules its work on how the immune system communicates with tissues that have been...
aptaTargets announces first patient dosed in the clinical trial of ApTOLL for COVID-19
The study will evaluate the safety and efficacy of ApTOLL in 30 patients with COVID-19 at four Spanish hospitals
Venture capital plays key role in fight against cancer
On 28 April, AseBio Investor Day will bring together more than 50 investors from all over the world with disruptive...
Two chemists who founded Sanifit: “Biotech entrepreneurship isn’t a sprint. It’s an ultram...
Two chemists, when they had barely turned 25, set up a spin-off of the University of the Balearic Islands that has just...
3P Biopharmaceuticals and Buzzard Pharmaceuticals start a collaboration to develop a new t...
3P Biopharmaceuticals and Buzzard Pharmaceuticals have entered into a partnership agreement for manufacturing of the...
